Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM1A | O60341 | 1/20 | 0.33 |
| ▸ | RCOR1 | Q9UKL0 | 1/20 | 0.33 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.31 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.31 |
| ▸ | P2RX7 | Q99572 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17783276 | 1.00 | KDM1A (0.33) | KDM1ARCOR1RIPK1TAAR1P2RX7 | |
| SCHEMBL17787978 | 0.84 | FFAR4 (0.32) | — | |
| SCHEMBL17783272 | 0.84 | — | — | |
| SCHEMBL17783273 | 0.84 | — | — | |
| SCHEMBL28525537 | 0.83 | FFAR4 (0.35) | — | |
| SCHEMBL17783295 | 0.81 | FFAR4 (0.34) | — | |
| SCHEMBL17783294 | 0.81 | FFAR4 (0.34) | — | |
| SCHEMBL17783292 | 0.80 | FFAR4 (0.31) | — | |
| SCHEMBL17783291 | 0.80 | FFAR4 (0.31) | — | |
| SCHEMBL17788445 | 0.80 | FFAR4 (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9637466-B2 | Liquid crystal compound having 2, 6-difluorophenyl ether structure and liquid crystal composition thereof | DIC CORPORATION (JP) | 2017-05-02 | — | — | US | disclosed |
| US-20160152589-A1 | LIQUID CRYSTAL COMPOUND HAVING 2, 6-DIFLUOROPHENYL ETHER STRUCTURE AND LIQUID CRYSTAL COMPOSITION THEREOF | DIC CORPORATION (JP) | 2016-06-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160152589-A1 | LIQUID CRYSTAL COMPOUND HAVING 2, 6-DIFLUOROPHENYL ETHER STRUCTURE AND LIQUID CRYSTAL COMPOSITION THEREOF | FGFR1, FGF1, FGFR2 | KDM1A 1384/4885RCOR1 4204/4885RIPK1 1392/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.